Healthcare provider profile · identity verified

Pramod Multani, MD

Cardiology · DOWNEY, CA · NPI 1407968746

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	728	256
Amlodipine Besylate	Amlodipine Besylate	544	168
Metformin Hcl	Metformin Hcl	375	131
Losartan Potassium	Losartan Potassium	331	112
Levothyroxine Sodium	Levothyroxine Sodium	328	99
Lisinopril	Lisinopril	265	91
Tamsulosin Hcl	Tamsulosin Hcl	241	79
Omeprazole	Omeprazole	234	83
Trazodone Hcl	Trazodone Hcl	190	47
Gabapentin	Gabapentin	169	61
Simvastatin	Simvastatin	167	53
Carvedilol	Carvedilol	161	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	150	24
Rosuvastatin Calcium	Rosuvastatin Calcium	149	57
Baclofen	Baclofen	144	48
Potassium Chloride	Potassium Chloride	141	39
Metoprolol Succinate	Metoprolol Succinate	140	47
Clopidogrel	Clopidogrel Bisulfate	134	41
Albuterol Sulfate Hfa	Albuterol Sulfate	133	50
Furosemide	Furosemide	132	44
Metoprolol Tartrate	Metoprolol Tartrate	131	39
Alendronate Sodium	Alendronate Sodium	130	43
Jardiance	Empagliflozin	127	40
Hydrochlorothiazide	Hydrochlorothiazide	126	44
Allopurinol	Allopurinol	118	40
Eliquis	Apixaban	116	26
Atenolol	Atenolol	109	33
Ibuprofen	Ibuprofen	98	39
Benazepril Hcl	Benazepril Hcl	88	27
Ipratropium Bromide	Ipratropium Bromide	88	16
Famotidine	Famotidine	87	31
Pantoprazole Sodium	Pantoprazole Sodium	86	33
Diclofenac Sodium	Diclofenac Sodium	85	35
Pioglitazone Hcl	Pioglitazone Hcl	82	24
Glimepiride	Glimepiride	80	27
Naproxen	Naproxen	80	32
Alprazolam	Alprazolam	78	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	77	38
Glipizide	Glipizide	76	25
Fluticasone Propionate	Fluticasone Propionate	75	29
Ibandronate Sodium	Ibandronate Sodium	73	25
Buspirone Hcl	Buspirone Hcl	69	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	20
Ozempic	Semaglutide	67	13
Finasteride	Finasteride	63	22
Januvia	Sitagliptin Phosphate	62	20
Mupirocin	Mupirocin	62	31
Donepezil Hcl	Donepezil Hcl	61	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	22
Hydralazine Hcl	Hydralazine Hcl	56	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	55	38
Tramadol Hcl	Tramadol Hcl	55	26
Montelukast Sodium	Montelukast Sodium	51	18
Enulose	Lactulose	49	suppressed
Lorazepam	Lorazepam	49	suppressed
Meclizine Hcl	Meclizine Hcl	49	28
Meloxicam	Meloxicam	49	12
Pravastatin Sodium	Pravastatin Sodium	49	15
Duloxetine Hcl	Duloxetine Hcl	48	16
Nitroglycerin	Nitroglycerin	46	23
Xarelto	Rivaroxaban	46	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	12
Doxazosin Mesylate	Doxazosin Mesylate	42	15
Lovastatin	Lovastatin	41	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	40	13
Valsartan	Valsartan	38	suppressed
Amiodarone Hcl	Amiodarone Hcl	35	11
Clonidine Hcl	Clonidine Hcl	35	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	13
Escitalopram Oxalate	Escitalopram Oxalate	32	11
Ezetimibe	Ezetimibe	32	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	30
Sertraline Hcl	Sertraline Hcl	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Azithromycin	Azithromycin	29	22
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Prednisone	Prednisone	29	suppressed
Synthroid	Levothyroxine Sodium	29	12
Colchicine	Colchicine	26	11
Chlorthalidone	Chlorthalidone	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Linzess	Linaclotide	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Clonazepam	Clonazepam	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Digoxin	Digoxin	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Celecoxib	Celecoxib	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Methylprednisolone	Methylprednisolone	17	15
Nifedipine Er	Nifedipine	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Glipizide Er	Glipizide	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Temazepam	Temazepam	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Colesevelam Hcl	Colesevelam Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Lactulose	Lactulose	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error